Feasibility of a Patient Directed Tool to Assess Heart Health Among Endometrial Cancer Survivors
- Conditions
- SurvivorshipEndometrial Cancer
- Registration Number
- NCT05796518
- Lead Sponsor
- Wake Forest University Health Sciences
- Brief Summary
Investigators are conducting this study to find out more about what heart health means to participants and how healthcare providers can best help to manage heart health. Participants will be asked to view an electronic tool designed to promote heart health awareness and help to manage heart health outside of the clinic. This study will provide important information to help investigators develop future programs that improve cancer patient's heart health after they complete their treatment.
- Detailed Description
Primary Objective: The primary objective of this pilot study is to assess the feasibility of enrolling and completing the heart health assessment among endometrial cancer patients scheduled for routine follow-up care.
Secondary Objectives:
* To assess patient satisfaction with the tool.
* To identify the proportion of patients with non-ideal cardiovascular health scores who report initiating discussions regarding cardiovascular health during their routine oncology appointment.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 44
- Scheduled for a routine surveillance visit for pathologically confirmed stages I-IV endometrial cancer
- Greater than or equal to 3 months post-potentially curative cancer treatment
- Patients must be at least 18 years of age
- Have a working email address
- Comfortable reading medical information in English, as per self-report
- Currently receiving treatment (e.g. radiation, chemotherapy, immunological treatments for endometrial cancer)
- Have a history of endometrial cancer recurrence
- Enrolled in hospice care or documentation of life expectancy < 6 months
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Number of Participants to Complete Intervention - Feasibility 6 months Feasibility will be defined from the number of participants who complete the web-based assessment using exact 95% binomial confidence intervals.
- Secondary Outcome Measures
Name Time Method Number of Participants Stating Satisfaction With PREVENT Tool 6 months Patient satisfaction will be identified through post-visit survey with a 5-point Likert scale (strongly agree to strongly disagree) regarding liking the tool, helpfulness, ease of understanding and desire to use this tool with their oncologist. One-sample t-tests will be used to test whether the average response to each question is greater than 3.5 (with three denoting a neutral response). Wilcoxon signed rank tests will be used to compare cancer survivors' knowledge regarding their cardiovascular health risk factors and perceived importance of cancer and heart disease before and after using the cardiovascular risk visualization tool.
Number of Participants to Report Initiating Discussions Regarding Cardiovascular Health With Health Care Providers 6 months The initiation of discussions with participants' health care providers will largely be descriptive (using means as a measurement) to analyze this measure. Participants responded yes/no to the following discussions:
1) Losing weight and maintaining a healthy body weight? 2) Quitting smoking, or staying smoke-free? 3) Controlling your blood pressure? 4) Controlling your cholesterol? 5) Controlling your glucose or hemoglobin A1c? 6) Any discussion regarding health with health care providers
Trial Locations
- Locations (1)
Wake Forest Baptist Comprehensive Cancer Center
🇺🇸Winston-Salem, North Carolina, United States
Wake Forest Baptist Comprehensive Cancer Center🇺🇸Winston-Salem, North Carolina, United States